Nevada Board of Pharmacy opens public hearing on proposed NAC 453.510 Schedule I additions (dipentylone + seven fentanyl-related substances)

The Nevada State Board of Pharmacy posted a Notice of Intent to act upon a regulation and scheduled a public hearing to amend NAC 453.510 (Schedule I) to add dipentylone and seven fentanyl-related substances to Nevada Schedule I, stated as conforming with federal Uniform Controlled Substances Act scheduling. If adopted, these substances would become Schedule I controlled substances in Nevada, impacting screening, handling/registration controls, and potential enforcement risk for entities that manufacture, distribute, dispense, or otherwise handle controlled substances in Nevada. The notice also sets the opportunity for stakeholder participation via the hearing and written comments.